| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
8,826 |
7,975 |
$2.49M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
3,805 |
3,440 |
$1.72M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
1,766 |
1,564 |
$1.42M |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
1,230 |
1,178 |
$215K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
3,583 |
1,349 |
$197K |
| 80061 |
Lipid panel |
965 |
917 |
$128K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
6,012 |
5,243 |
$73K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
31 |
30 |
$47K |
| 71046 |
Radiologic examination, chest; 2 views |
1,131 |
1,049 |
$35K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
2,030 |
1,859 |
$23K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
1,484 |
629 |
$17K |
| 97161 |
|
100 |
98 |
$16K |
| 70450 |
Computed tomography, head or brain; without contrast material |
79 |
76 |
$13K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
1,200 |
1,141 |
$13K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
14 |
12 |
$12K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
1,314 |
1,164 |
$10K |
| 80053 |
Comprehensive metabolic panel |
4,532 |
3,999 |
$9K |
| 71045 |
Radiologic examination, chest; single view |
1,454 |
1,294 |
$6K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
158 |
144 |
$6K |
| 73630 |
|
105 |
102 |
$4K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
1,308 |
1,207 |
$4K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
1,508 |
1,330 |
$4K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
1,972 |
1,740 |
$4K |
| 87070 |
|
220 |
205 |
$3K |
| A9270 |
Non-covered item or service |
10,487 |
5,781 |
$3K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
1,319 |
1,260 |
$3K |
| 84443 |
Thyroid stimulating hormone (TSH) |
805 |
771 |
$2K |
| 85027 |
|
187 |
151 |
$2K |
| 84484 |
|
1,460 |
1,100 |
$801.47 |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
2,197 |
1,825 |
$705.96 |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
40 |
39 |
$692.19 |
| 12001 |
|
12 |
12 |
$536.24 |
| 73030 |
|
13 |
13 |
$441.39 |
| 80050 |
General health panel |
16 |
16 |
$319.53 |
| Q3014 |
Telehealth originating site facility fee |
1,932 |
1,778 |
$228.96 |
| 84703 |
|
945 |
902 |
$228.59 |
| 81001 |
|
2,893 |
2,613 |
$161.48 |
| 85610 |
|
59 |
54 |
$133.64 |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
54 |
52 |
$131.26 |
| 36415 |
Collection of venous blood by venipuncture |
7,489 |
6,259 |
$120.44 |
| 80305 |
|
66 |
60 |
$65.29 |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
184 |
161 |
$51.30 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
777 |
715 |
$47.54 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
599 |
536 |
$32.00 |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
2,764 |
1,790 |
$30.86 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
70 |
67 |
$16.78 |
| 80076 |
|
13 |
13 |
$14.85 |
| 83690 |
|
983 |
900 |
$12.75 |
| 83735 |
|
347 |
293 |
$5.96 |
| Q0162 |
Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
28 |
27 |
$0.03 |
| 96375 |
Therapeutic injection; each additional sequential IV push |
348 |
314 |
$0.00 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
37 |
37 |
$0.00 |
| 87040 |
|
43 |
24 |
$0.00 |
| 85730 |
|
12 |
12 |
$0.00 |
| 83605 |
|
113 |
94 |
$0.00 |
| 85651 |
|
26 |
26 |
$0.00 |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
12 |
12 |
$0.00 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
287 |
262 |
$0.00 |
| 84439 |
|
54 |
53 |
$0.00 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
120 |
103 |
$0.00 |
| 90715 |
|
13 |
12 |
$0.00 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
48 |
47 |
$0.00 |
| 85007 |
|
258 |
212 |
$0.00 |
| 82947 |
|
34 |
25 |
$0.00 |
| G8979 |
Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
75 |
65 |
$0.00 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
29 |
24 |
$0.00 |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
24 |
24 |
$0.00 |